Long term clinical outcome after success re-attempt percutaneous coronary intervention of chronic total occlusion

• Published in: BMC cardiovascular disorders Vol. 23; no. 1; p. 23
• Main Authors: Li, Wenzheng, Wu, Zheng, Liu, Tong, Wu, Xiaofan, Liu, Jinghua
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 16.01.2023; BioMed Central; BMC
• Subjects: Angina Pectoris - etiology; Arterial occlusions; Care and treatment; Chronic Disease; Chronic total occlusion; Coronary Angiography - adverse effects; Coronary heart disease; Coronary Occlusion - diagnostic imaging; Coronary Occlusion - surgery; Humans; Long-term outcomes; MACE; Myocardial Infarction; Patient outcomes; Percutaneous coronary intervention; Percutaneous Coronary Intervention - adverse effects; Reoperation; Retrospective Studies; Risk Factors; Statistics; Transluminal angioplasty; Treatment Outcome; TVR; China; Long-term outcomes; TVR; Percutaneous coronary intervention; MACE; Chronic total occlusion
• ISSN: 1471-2261; 1471-2261
• DOI: 10.1186/s12872-023-03045-w

To evaluate the long-term outcome after re-attempt CTO-PCI. This is a retrospective cohort study that included 113 re-attempt CTO-PCI patients who were consecutively registered from January 2019 to December 2020 at Beijing Anzhen Hospital's Center of Coronary Artery Disease. All patients were divided into two groups based on procedural success or failure. The primary endpoint was major adverse cardiac events (MACE), a composite of all-cause mortality, myocardial infarction and target vessel revascularization (TVR). The secondary endpoint was angina after PCI. Overall, the successful re-attempt CTO-PCI was archived in 77 patients, the failed CTO-PCI was performed in 36 patients. After a median follow-up of 21.7 months (interquartile range: 10.9-26.0), the incidence of the primary outcome was significantly lower in the success group [14.2% vs. 38.9%, adjusted hazard ratio (HR) 0.351, 95% CI 0.134-0.917, P = 0.033], mainly driven by the reduction of TVR (9.1% vs. 30.6%, adjusted HR 0.238, 95% CI: 0.078-0.72, P = 0.011). Furthermore, patients who had successful re-attempt CTO-PCI had a lower risk of angina after PCI (27.3% vs.61.1%, adjusted HR 0.357, 95% CI 0.167-0.76, P = 0.008). The risk factors of TVR in the patients with successful re-attempt CTO-PCI were stent length > 100 mm (adjusted HR 21.805, 95% CI 1.765-269.368, P = 0.016) and J-CTO score > 3(adjusted HR: 9.733, 95% CI:1.533-61.797, P = 0.016). For the patients with previous CTO-PCI failure, a successful re-attempt CTO-PCI was associated with significantly lower MACE, which was primarily driven by a lower TVR rate. More complex CTO lesions and longer stents were the independent predictors of TVR after successful CTO-PCI.